Skip to main content

Advertisement

Table 2 Data on surgical procedures and oncological outcome by treatment group

From: Total laparoscopic hysterectomy versus total abdominal hysterectomy with bilateral salpingo-oophorectomy for endometrial carcinoma: a randomised controlled trial with 5-year follow-up

  LH (n = 11) AH (n = 6) P value
Intra-operative laparoconversion 1 (9%) n.a. n.a.
Operation time (min) 122 [96–168] 80 [70–192] 0.03
Blood loss (mL) 200 [0–550] 350 [300–1450] 0.01
Hospitalization (days) 5 [4–16] 8 [5–11] 0.03
Clinical follow-up (months) 54 [18–80] 64 [50–81] 0.09
Diseased after recurrence 2 (18%) 0 0.40
Postoperative histology
 Normal 1 (9%) 0  
 Atypical hyperplasia 0 1 (17%)  
 Endometrial carcinomaa 10 (91%) 5 (83%) 0.60
Postoperative radiotherapy 3 (27%) 3 (50%) 0.34
  1. Data shown as absolute numbers (percentage) or median [range]. p = p value for differences between groups using Fisher's exact test in cases of 2-by-2 tables, and Mann–Whitney test in cases of non-normal distributed numerical variables
  2. AH abdominal hysterectomy, LH laparoscopic hysterectomy, n.a. not applicable
  3. aEndometrial carcinomas were stage 1b grade 1 (2 patients), 1c grade 1, 2a grade 1, and 3a grade 1 in the AH group, and 1a grade 1, 1b grade 1 (3 patients), 1b grade 2, 1c grade 1, 1c grade 2 (2 patients), 2b grade 1 and 3a grade 2 in the LH group. All histologies showed endometroid type adenocarcinoma, except one woman in the LH group with stage 3a grade 2 mixed cell-type tumour (endometroid and serous adenocarcinoma)